Israel
Tuberculosis profile
Population  2013 7.7 million
Estimates of TB burden * 2013 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) 0.016 (0.016–0.016) 0.21 (0.2–0.21)
Mortality (HIV+TB only) <0.01 (<0.01–<0.01) 0.01 (0.01–0.02)
Prevalence  (includes HIV+TB) 0.55 (0.22–1) 7.1 (2.9–13)
Incidence  (includes HIV+TB) 0.45 (0.42–0.49) 5.8 (5.5–6.4)
Incidence (HIV+TB only) 0.013 (0.013–0.015) 0.17 (0.16–0.19)
Case detection, all forms (%) 68 (63–73)    
Estimates of MDR-TB burden * 2013   New   Retreatment
% of TB cases with MDR-TB 3.8 (1.4–8.2) 100 (2.5–100)
MDR-TB cases among notified pulmonary
TB cases
9 (3–18) 3 (0–3)
TB case notifications 2013 New ** Relapse
Pulmonary, bacteriologically confirmed 163   1
Pulmonary, clinically diagnosed 60   2
Extrapulmonary 81   1
       
Total new and relapse 308    
Previously treated, excluding relapses 0    
Total cases notified 308    
Among 308 new and relapse cases:
15 (5%) cases aged under 15 years; male:female ratio: 2.1
Reported cases of RR-/MDR-TB 2013 New Retreatment Total **
Cases tested for RR-/MDR-TB 208 (128%) 2 (50%) 210
Laboratory-confirmed RR-/MDR-TB cases     8
Patients started on MDR-TB treatment     8
TB/HIV 2013 Number (%)
TB patients with known HIV status 292 (95)
HIV-positive TB patients 15 (5)
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT)    
HIV-positive TB patients on antiretroviral therapy (ART)    
HIV-positive people screened for TB    
HIV-positive people provided with IPT    
Treatment success rate (%)
New and relapse cases registered in 2012 81
Previously treated cases, excluding relapse, registered in 2012  
HIV-positive TB cases, all types, registered in 2012 75
RR-/MDR-TB cases started on second-line treatment in 2011 64
XDR-TB cases started on second-line treatment in 2011  
Laboratories 2013  
Is second-line drug susceptibility testing available? Yes, in country
Financing TB control 2014  
National TB programme budget (US$ millions)  
* Ranges represent uncertainty intervals
** Includes cases with unknown previous TB treatment history
***
(Rate per 100 000 population per year)
Mortality graph
   Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
   Prevalence

(Rate per 100 000 population per year)
Incidence graph
   Notified (new and relapse)   Incidence
   Incidence (HIV+TB only)

(Number of patients)
CPT ART graph
   HIV-positive TB patients
   on CPT   on ART

Treatment success rate (%)
tx success graph
   New   Retreatment
   New and relapse   Retreatment, excluding
relapse
   HIV-positive   RR-/MDR-TB   XDR-TB

 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 Generated: 2015-09-01 Data: www.who.int/tb/data